CS Paper Radar

AMP Atlas: A Browser-Only Workbench for Antimicrobial Peptide Exploration and Interactive Helical-Wheel Design

Truong-Son Hy

cs.CE ·submitted 2026-10-21 02:41 UTC · v1
code/data

Abstract

Accessible research software can connect published antimicrobial peptide (AMP) records to sequence analysis, molecular visualization, and interactive design without requiring a dedicated application server. We present AMP Atlas, an open-source, browser-only workbench that combines a DRAMP-derived database with local physicochemical calculations, published-neighbor retrieval, and sequence-guided structural comparison. The reported snapshot contains 12,784 source records, 10,579 canonical records, 5,183 source SMILES annotations, and 433 PDB chain structures. An inverse helical-wheel editor lets users specify peptide length, fill residues gradually, and immediately retrieve exact-length database matches under positional and property constraints. Selected-position residue frequencies support further editing while preserving the remaining constraints. A Web Worker performs searches and numerical calculations; a WebGL viewer provides interactive molecular representations. The static distribution occupies 138.8 MB and supports GitHub Pages hosting. Verification includes 23 Python tests, 30 browser-core/worker checks, a designer DOM integration suite, and agreement against fixed numerical references. This report describes the implemented algorithms and assumptions; it does not establish predictive accuracy for antimicrobial activity or experimentally validate designed peptides. The website is available at https://hysonlab.github.io/amp-atlas/ and the source code and database are available at https://github.com/HySonLab/amp-atlas

Closest papers

Nearest neighbours by meaning across the whole index.

PeptSol: A Translational Benchmark for Protected-Peptide Solubility in Drug Manufacturing

cs.LG physics.chem-phq-bio.BM ·2026-10-31 ·Alexander Arjun Lobo, Marc Saouda, Urvi Awasthi, Leonid Zhukov
publishedbenchmark similarity 0.62
Abstract · 15 pages, 1 figure, 19 tables. Accepted at the AI for Drug Discovery workshop, NeurIPS 2026

Liquid-phase peptide synthesis (LPPS) offers a scalable route to peptide manufacturing, but route development still depends on empirical solvent screens because each protected intermediate must be soluble for reaction and recoverable for purification. The protecting groups, terminal modifications, and noncanonical residues that govern this behaviour are poorly represented in existing peptide property benchmarks, limiting the ability to develop and rigorously evaluate molecular representation models for LPPS-relevant prediction tasks. We introduce PeptSol, an open benchmark of 1388 hand-curated protected-peptide solubility measurements with chemistry-aware splits. The measurements span only 84 parent sequences and 101 protected structures, and 92.5% come from a single historical programme. Across seven frozen molecular encoders, the best macro-F1 is 0.843 on binary solubility for the historical subset under a peptide-held-out split; the harder three-class ordinal task reaches 0.614 in that cell. No foundation model consistently outperforms a baseline combining chemical fingerprints with explicit molecular descriptors, and model rankings vary across prediction tasks and data splits. The dataset, evaluation protocol, and baselines establish a standard for measuring progress on molecular representations for synthesis-aware peptide developability.

0.31

Toward a Locally Deployable Agentic Co-Scientist: Small-Model Planning for Early-Stage Drug Discovery

cs.AI ·2026-10-03 ·Tian Liang, Jiayu Chang, Alejandro F. Frangi, Mobarak I. Hoque, Richard A. Bryce
published similarity 0.57
Abstract · 22 pages, 4 figures. Accepted at the AI for Drug Discovery Workshop, NeurIPS 2026

Early-stage computational drug discovery requires coordinating heterogeneous scientific tools across multi-step workflows. We present a lightweight, tool-augmented framework in which a locally deployable compact language model plans calls to 18 modular tools. A Unified Molecular Schema maintains shared molecular records, while a plug-in interface supports tool replacement and extension. We construct 1,263 manually refined query-plan pairs through workflow-graph path coverage and apply LoRA fine-tuning to three compact model families. Under the query-level split, all fine-tuned models generate fully parseable and schema-compliant plans on 47 held-out cross-group queries. Llama 3.2-3B achieves a tool-selection F1 of 0.998, sequence exact match of 0.979, and argument F1 of 0.960. Under the stricter workflow-grouped split, which excludes identical ordered tool sequences across partitions, sequence exact match reaches 0.452 to 0.548, highlighting the remaining difficulty for compact models in generating complete workflow paths unseen during training. These results demonstrate the feasibility of compact, locally deployable planning while identifying compositional generalization as an important direction for further improvement.

0.33

A curated multi-endpoint drug-protein bioactivity dataset with construct-aware protein targets

cs.LG ·2026-10-23 ·Lina Abou-Abbas, Nour Mhanna, Hasan Bazzi, Sleiman El Hajj, Abdulkader Helwan +2 more
dataset similarity 0.57
Abstract

Public drug-protein bioactivity resources commonly identify targets by UniProt accession, although one accession may represent distinct experimental sequences. We present Curate-DTI, a construct-aware dataset derived from the 1 July 2026 BindingDB export, with IC50, Ki, Kd and EC50 processed independently. The release contains 2,919,717 measurements, 1,291,872 standardized ligands, 9,668 sequence-defined protein entities and 2,275,683 endpoint-specific interactions spanning 8,336 reviewed UniProt accessions. Protein entities combine the accession with the reported experimental sequence, preserving constructs that accession-only processing would merge. Across the four endpoints, 4,204 endpoint-specific ligand-accession groups showed different classification labels across sequence-defined protein entities. Exact and inequality-qualified observations provide relation-aware classification evidence, whereas regression targets use exact values only. Connected Parquet tables preserve individual measurements, standardized structures, protein sequences, aggregated interactions and available assay and source provenance. The resource supports endpoint-specific classification and regression while allowing users to select molecular representations, protein representations and evaluation splits. Preprocessing code, a column dictionary, exclusion reports and validation summaries accompany the release.

0.26

Mirror-Score: Calibrated, Inference-only Scoring Exposes the Limits of Sequence-compatibility Ranking in D-peptide Design

cs.AI cs.CEcs.ETcs.LG+1 ·2026-09-28 ·Jiada Li
benchmarkcode/data similarity 0.57
Abstract

D-peptides combine protease resistance with high target specificity, but computational design of D-peptide binders remains immature. Mirror-Peptidizer introduced an in silico mirror-image screening pipeline using target reflection, backbone generation, and ProteinMPNN sequence design, but its raw ProteinMPNN negative log-likelihood (NLL) ranking was not validated against measured affinities, and only 4 of 9 tested MDM2 designs bound detectably. We introduce Mirror-Score, a calibrated, inference-only scoring framework for heterochiral D-peptide/L-protein complexes, and a public benchmark of 31 crystal complexes across four target families, including 18 with literature-verified affinities. Raw ProteinMPNN NLL is not a valid affinity ranker: its pooled Spearman correlation with affinity is 0.19, and correlations reverse between MDM2/CHIP (+0.62) and gp41 (-0.70). We therefore evaluate Boltz-2 mirror-space cofolding confidence. For the complete viral-entry family (7 structures representing 3 peptides), interface predicted local distance difference test (pLDDT) achieves structure-level leave-one-out Spearman rho = 0.90 (p = 0.006) and correctly orders all three peptides by affinity, whereas NLL fails (structure-level rho = 0.18). Because only three independent chemotypes are represented, this result indicates directional consistency rather than a statistically validated predictor. Cross-family calibration does not transfer at current sample sizes, supporting family-matched calibration as the practical deployment mode. We also specify a prospective design protocol for the antimicrobial-resistance targets LasR and LecB from Pseudomonas aeruginosa, including mirrored structures, ligand-derived hotspot maps, diffusion-model-ready inputs, and Mirror-Score ranking. Code, benchmark data, structures, and analysis scripts are openly available at https://github.com/Jiadalee/Mirror-Score.

0.38

El Agente Fármaco: A Scalable AI Scientist for Drug Discovery

cs.AI cs.MAq-bio.BM ·2026-11-02 ·Marcel Müller, Mohammad Ghazi Vakili, Yoshihiro Ogura, Ella Ashoori, Shimeng Wang +11 more
benchmark similarity 0.56
Abstract · 63 pages, 13 figures, including Supporting Information

Computational drug discovery offers a growing range of tools for proposing and evaluating molecules, but combining them and deciding what to do next still requires substantial expert effort. Here, we introduce El Agente Fármaco, an AI scientist that uses modern large language model (LLM) technology to turn discovery goals expressed in everyday language into complex, scalable computational screening workflows. The agentic harness selects scientific tools, reviews their results, and adjusts subsequent steps to the target and the user's objectives. Our approach centers on a shared scientific memory: Fármaco Atlas, which stores molecules, structures, and results together with their provenance -- a record of how they were obtained. The agent uses targeted database queries to retrieve the evidence needed for each decision. A single request can launch calculations for an entire collection of molecules, without requiring a separate LLM decision for every compound. This design limits the information the model must process as screening collections grow, while keeping the underlying results available for inspection and further analysis. The integrated tools support molecule generation, prediction of binding and molecular properties, and searches for compounds available for purchase. In a retrospective comparison with an expert-led campaign, the agent proposed chemically distinct candidates with competitive docking scores and higher calculated drug-likeness under explicitly imposed selection criteria. In a 22-task benchmark against plain tool calls and Codex, the agent achieved the highest observed mean model-judged score, with lower median cumulative token use and peak context. Fármaco provides a foundation for flexible, scalable drug discovery workflows that connect scientific reasoning with an enduring, traceable record of computational work.

0.08

FoldKit: A Python library for efficient storage and retrieval of co-folding predictions

cs.SE q-bio.QM ·2026-08-28 ·Jonathan A. Levine, Melissa Pathil, Samuel Nitz, Olga Lyudovyk, Benjamin D. Greenbaum
benchmark similarity 0.56
Abstract · 7 pages, 3 figures. Software: http://pypi.org/project/foldkit/. Documentation: http://pypi.org/project/foldkit/

AlphaFold 3 (AF3) enables structure prediction of biomolecular complexes through co-folding multiple interacting molecules, making it increasingly useful for de novo protein design and for large-scale studies of protein-protein, protein-peptide, and other biomolecular interactions. However, systematic co-folding experiments can produce large volumes of output data, particularly when multiple random seeds and samples are generated for each input complex. We introduce FoldKit, a Python package for efficient storage and analysis of large-scale AF3 co-folding results. FoldKit converts raw AF3 outputs into a compact, structured representation while preserving the metadata needed for downstream analysis. The FoldKit Python library provides convenient programmatic access to global, single chain, and interface confidence metrics such as pLDDT, pTM, ipTM, ipAE, and ipSAE, as well as an ensemble-level interface for accessing and aggregating these metrics for a single input across multiple seeds and samples. We benchmark FoldKit on three types of AF3 co-folding datasets: (i) a protein design campaign with 2 chains per input, (ii) a TCR-pMHC dataset with 4 chains per input, and (iii) a pooled-AF3 protein-protein interaction dataset with up to 22 chains per input. We find that FoldKit reduces storage requirements by approximately 5-15-fold compared to native AF3 outputs, depending on dataset composition, while maintaining direct programmatic access to individual predictions, ensembles, and confidence metrics. By reducing storage requirements and facilitating programmatic access to relevant outputs, FoldKit facilitates large-scale computational studies of biomolecular interactions. FoldKit is available from PyPI and can be installed using pip.

0.20

Ensemble-Aware Structural Encoding (EASE): Conditioning Protein Encoders on Peptide Conformational Ensembles

cs.LG ·2026-10-20 ·Ruoyao Zhang, Hongxuan Li, Jie Peng, Tianlong Chen
similarity 0.56
Abstract

Protein foundation models provide transferable representations for downstream peptide prediction tasks. However, existing representations typically reduce a peptide to a single sequence or structure, which may miss conformational variability relevant to key peptide properties, including antibacterial activity, hemolysis, toxicity, stability, and binding. For example, protease resistance correlates more strongly with conformational dynamics measured by hydrogen exchange than with average helicity. Therefore, we introduce Ensemble-Aware Structural Encoding (EASE), a framework for effectively extracting structural information from conformational ensembles for peptide representation. To extract useful information from noisy conformers, EASE selects central conformers representing a peptide's major structural states and fuses their individual representations with a permutation-invariant operator to produce a peptide-level representation for downstream prediction. We then evaluate our framework on six peptide property-prediction tasks under leakage-controlled splits. Against matched single-structure baselines, EASE improves performance consistently on six tasks with a mean absolute gain of about 3.0% across two structural encoders. Gains keep growing as we add conformers through K=20. A single peptide conformer therefore provides a limited basis for structural representation, whereas our framework distilling and fusing multiple conformers yields a more informative representation.

0.24

ProteoCraft: Protein Design as Proposal-Verification Search

cs.CE cs.AIq-bio.BM ·2026-11-02 ·Fang Wu, Hongbin Lin, Bingchen Duan, Yuchen Wang, Li Erran Li +22 more
code/data similarity 0.56
Abstract

Protein-protein interactions underpin nearly all biological processes. Yet, designing proteins with desired interactions remains challenging due to the structural complexity governing molecular recognition. This study views protein design as a search optimization problem over a combinatorial sequence space under expensive structural evaluation. Toward this goal, we introduce a novel tree-based search framework, ProteoCraft, that employs approximate structural gradients from diffusion-based structure predictors as effective proposal policies to specify where the search should explore. Complete no-gradient inference of folding models separately assigns values to the resulting sequences, determining what is good. ProteoCraft allocates this verification budget through a coarse-to-fine paradigm: multi-site edits first explore distinct sequence basins, then verified promising states undergo strict single-site refinement. Across fourteen de novo binder-design settings spanning eight target proteins, five immune-relevant TCR-facing targets, and four localized CDR redesign tasks, ProteoCraft improves design quality and high-confidence yield. These improvements persist under independent AF2-IG and Rosetta-based interface evaluation. Prospective experimental validation further yielded an 82.9% binding hit rate for PD-L1 miniproteins, with a best measured KD of 0.879 nM, and confirmed binding of designed IFNAR2 VHH. Our code is available at https://github.com/smiles724/ProteoCraft_v1.

0.28